Actinic Keratosis Clinical Trials
Here are the 6 most popular medical studies for actinic keratosis
Immunomodulator
Imiquimod cream 3.75% for Actinic Keratosis
The purpose of this study is to determine the potential effect of topically applied 3.75% imiquimod cream on atrial ectopy in actinic keratosis (AK) patients. The primary endpoint is the change in the 24-hour supraventricular premature beat count. The secondary endpoint is the change in 24-hour supraventricular premature couplet and run counts and atrial fibrillation (% time); change in 24-hour mean heart rate; change in 24-hour ventricular premature beat count, ventricular premature couplet and run counts.
Popular filter options for actinic keratosis trials
AK Clinical Trials
View 13 AK medical studies.
Procedure
Fractionated Laser Resurfacing for Actinic Keratosis and Skin Cancer Prevention
This trial is testing if a fractionated laser resurfacing treatment can help to remove actinic keratosis, and also if it can help to reduce the levels of future actinic keratosis and other non-melanoma skin cancers, in comparison to an untreated arm. The study length is 5 years, with the first part completed in 1 day, and follow up visits at 90 days and every 6 months.
Photosensitizer
Photodynamic Therapy for Actinic Keratosis
This trial is testing a new way to treat actinic keratosis using light. People in the Chicago area who are interested and meet the requirements are randomly chosen to either have no incubation time with the 5-aminolevulinic acid or 1 hour. There are 3 visits total, and this study is to see if the new method is possible.
Actinic Keratosis Clinical Trials With No Placebo
View 16 actinic keratosis medical studies that do not have a placebo group.
Procedure
Fractionated Laser Resurfacing for Actinic Keratosis and Skin Cancer Prevention
This trial is testing if a fractionated laser resurfacing treatment can help to remove actinic keratosis, and also if it can help to reduce the levels of future actinic keratosis and other non-melanoma skin cancers, in comparison to an untreated arm. The study length is 5 years, with the first part completed in 1 day, and follow up visits at 90 days and every 6 months.
Photosensitizer
Photodynamic Therapy for Actinic Keratosis
This trial is testing a new way to treat actinic keratosis using light. People in the Chicago area who are interested and meet the requirements are randomly chosen to either have no incubation time with the 5-aminolevulinic acid or 1 hour. There are 3 visits total, and this study is to see if the new method is possible.
Frequently Asked Questions
Introduction to actinic keratosis
What are the top hospitals conducting actinic keratosis research?
When it comes to advancing the treatment options for actinic keratosis, several hospitals are leading the way. In Delray Beach, Florida, Dermatology Associates PA of the Palm Beaches is at the forefront with one active clinical trial dedicated to this condition. While they may have just begun their journey in researching actinic keratosis trials in 2022, their commitment to finding innovative solutions cannot be underestimated. Meanwhile, Gwinnett Clinical Research Center, Inc. located in Snellville has also made significant strides with five completed trials and one ongoing study specifically focused on actinic keratosis since initiating research back in 2012.
In Phoenix too there exists a strong presence of medical centers actively engaged in investigating new treatments for actinic keratosis. Medical Dermatology Specialists proudly conducts one active trial alongside three previously conducted studies on this condition since recording its first investigation back in 2017; while Alliance Dermatology & Mohs Center contributes through two prior experiments and an ongoing investigation which was initiated recently during2021.Finally, Dermatology Practice based out of Greenwood Village completes this list with its own contributions comprising similar findings as that exhibited by Alliance Dermatology & Mohs Center i.e two prior examinations alongwith conducting a current investigation from year ago likewise commencing newlyin2021.
These hospitals demonstrate a shared dedication towards finding better ways to treat and manage actinic keratosis - a common skin condition caused by prolonged sun exposure that can potentially develop into skin cancer if left untreated. Through their clinical trials and cutting-edge research efforts, these institutions are making valuable progress toward enhancing patient outcomes and improving quality of life for those affected by actinic keratosis not only within their respective communities but across wider regions as well
Which are the best cities for actinic keratosis clinical trials?
When it comes to actinic keratosis clinical trials, several cities are at the forefront of research. Phoenix, Arizona; Houston, Texas; Delray Beach, Florida; Snellville, Georgia; and Greenwood Village, Colorado each have active trials investigating treatments such as BF-200 ALA. These cities provide individuals with opportunities to participate in cutting-edge studies that aim to advance our understanding and management of actinic keratosis.
Which are the top treatments for actinic keratosis being explored in clinical trials?
In the realm of clinical trials for actinic keratosis, several potential treatments are being explored. Leading the charge is BF-200 ALA, currently involved in one active trial and two all-time actinic keratosis trials since its first listing in 2007. Another contender making waves is aminolevulinic acid hydrochloride gel, 10%, which has shown promise with one active trial and one all-time actinic keratosis trial recorded as of 2022. Last but not least, ALA (5-aminolevulinic acid) joins the ranks with one active trial and one all-time actinic keratosis trial since entering the scene in 2017. These ongoing efforts hold great potential to revolutionize treatment options for individuals facing this skin condition.
What are the most recent clinical trials for actinic keratosis?
Exciting developments are unfolding in the realm of actinic keratosis clinical trials, bringing new hope to those affected by this condition. One such trial involves BF-200 ALA, a groundbreaking treatment that has reached Phase 3. This therapy shows great promise in addressing actinic keratosis and its associated symptoms. Additionally, aminolevulinic acid hydrochloride gel, 10%, has progressed to Phase 4 with encouraging results for treating actinic keratosis. These advancements point towards more effective solutions for managing this skin disorder and improving patients' quality of life.
What actinic keratosis clinical trials were recently completed?
Several notable clinical trials for actinic keratosis have recently concluded, paving the way for advancements in its treatment. In June 2022, Almirall completed a trial investigating Tirbanibulin ointment 1%. This was followed by Encube Ethicals' completion of a trial involving Test Product (A): Fluorouracil Cream, 5% topical cream in March 2022. Additionally, Biofrontera Bioscience successfully wrapped up their BF-200 ALA and red light LED lamp study in December 2021. While further back in time, but still worth noting is Case Comprehensive Cancer Center's trial exploring Vitamin D3, which was completed in January 2020. These recent clinical trials highlight the dedication of researchers to finding effective treatments for actinic keratosis and offer hope to individuals facing this common skin condition.